Catalent Opens Expanded Oral Solid Dose FacilityBy
Catalent Pharma Solutions, a unit of Catalent, Inc., has opened a large-scale expansion at its Winchester, Kentucky, manufacturing facility, which doubled its footprint to 180,000 square feet. The expansion features newly installed fluid-bed capacity, expanded analytical laboratories, and an advanced, open facility design. The expansion was completed in response to increased customer demand for the manufacture of complex, oral solid formulations.
Construction work on the expansion began in 2013 with a $35 million facility investment, followed by a subsequent investment in additional fluid-bed capacity.The expansion will add as many as 140 new employees at the site with potential to add further employees and capabilities.
Catalent's Winchester facility has produced over 3 billion tablets and capsules annually and launched more than 100 new products into the market since its inception in 1992.